Active Ingredient(s):Cladribine FDA Approved: * March 29, 2019 Pharm Company: *EMD SERONO INC Category:Cancer
Cladribine, sold under the brand name Leustatin, among others, is a medication used to treat hairy cell leukemia (leukemic reticuloendotheliosis) and B-cell chronic lymphocytic leukemia.
cladribine, sold under the brand name Mavenclad, is indicated for the treatment of adult patients with highly active forms of relapsing-remitting multiple sclerosis.
Cladribine (2-chloro-2'-deoxyadenosine [2-CdA]) is a purine analogue that selectively t...
* May have multiple approval dates, manufacturers, or labelers.